Cargando…
An Activating Mutation of the NSD2 Histone Methyltransferase Drives Oncogenic Reprogramming in Acute Lymphocytic Leukemia
NSD2, a histone methyltransferase specific for methylation of histone 3 lysine 36 (H3K36), exhibits a glutamic acid to lysine mutation at residue 1099 (E1099K) in childhood acute lymphocytic leukemia (ALL), and cells harboring this mutation can become the predominant clone in relapsing disease. We s...
Autores principales: | Swaroop, Alok, Oyer, Jon A., Will, Christine M., Huang, Xiaoxiao, Yu, Wenbo, Troche, Catalina, Bulic, Marinka, Durham, Benjamin H., Wen, Qiang Jeremy, Crispino, John D., MacKerell, Alexander D., Bennett, Richard L., Kelleher, Neil L., Licht, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358490/ https://www.ncbi.nlm.nih.gov/pubmed/30171259 http://dx.doi.org/10.1038/s41388-018-0474-y |
Ejemplares similares
-
Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation
por: Popovic, Relja, et al.
Publicado: (2014) -
Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer
por: Zhao, Li-hao, et al.
Publicado: (2021) -
Covalent inhibition of NSD1 histone methyltransferase
por: Huang, Huang, et al.
Publicado: (2020) -
The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors
por: Chen, Rui, et al.
Publicado: (2020) -
The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)